HOME >> MEDICINE >> NEWS
Asthmatx completes enrollment in pivotal study of bronchial thermoplasty

San Francisco, CA, May 21, 2007 Asthmatx, Inc., a medical device company that has developed a catheter-based procedure for the treatment of asthma, announced today the successful completion of enrollment in its pivotal FDA approved IDE study, the Asthma Intervention Research 2 (AIR2) Trial of the Alair Bronchial Thermoplasty System. Bronchial Thermoplasty is a non-drug treatment for asthma under clinical investigation in the United States. The minimally invasive, bronchoscopic procedure uses thermal energy to reduce the airway smooth muscle responsible for constriction in asthma patients.

Leading asthma and bronchoscopy experts are participating in this international, multicenter AIR2 Trial to establish the safety and efficacy of the Alair System. Nearly 300 patients were enrolled in the study during the last 18 months at over 30 world-renowned medical centers including 15 US research hospitals. The AIR2 Trial is the fourth clinical study of the Alair Bronchial Thermoplasty System. To date, over 700 bronchoscopic procedures have been performed on asthma patients.

"We are very pleased to be a participant in this very important AIR2 Trial, the success of which will result in an important advancement in the treatment of severe asthma," states Mario Castro, MD, Associate Professor at the Washington University School of Medicine and Asthma Center, and a Principal Investigator in the AIR2 Trial. "As the lead enrolling center in the United States, we have experienced significant patient interest in bronchial thermoplasty, which we hope may become a new option for patients with difficult-to-treat asthma."

Final results of the first randomized and controlled clinical study of bronchial thermoplasty, the Asthma Intervention Research (AIR) Trial, were also reported today at the annual scientific assembly of the American Thoracic Society (ATS) by Gerard Cox, MB, Professor of Medicine, McMaster University, Canada, and principal investigato
'"/>

Contact: Meghan Oreste
moreste@comcast.net
617-823-1441
Asthmatx
21-May-2007


Page: 1 2

Related medicine news :

1. Acrux completes enrollment in key phase 2 trial
2. MacroChem completes patient enrollment for Phase II trial of EcoNail for treatment of onychomycosis
3. GroPep completes final milestone of the path malaria vaccine initiative
4. Im a Kid Too project completes first phase
5. Approval to start US BTT pivotal trial
6. Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
7. New data show CAS in clinical practice has comparable MAE rate with pivotal sapphire trial
8. Now is a pivotal point in history to abolish state execution
9. Orqis Medical receives unconditional FDA approval for pivotal trial of percutaneous CHF therapy
10. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
11. Penn study finds pro-death proteins required to regulate healthy immune function

Post Your Comments:
(Date:2/27/2015)... The Hermitage has responded to a ... that date back to 2012. The mitigation work that ... as it was approved in the summer of 2013. ... allegations we agreed to 100% mitigation at our expense," ... Company. , Barnes further added, "we were surprised and ...
(Date:2/27/2015)... 27, 2015 UAS LifeSciences, will showcase ... Natural Products Expo West, March 6 to 8 in ... to release the hands down best tasting probiotic in ... an extra zing of Vitamin C. This is a ... the NutrAward 2014, Delicious Living’s Supplement Award and Taste ...
(Date:2/27/2015)... 2015 According to the Center ... 38 million children and adolescents participate in sports ... a result of this growing number, new and ... and square footage creating a need for preventative ... , "Athletic facilities are hosting a record ...
(Date:2/27/2015)... GA (PRWEB) February 27, 2015 Leading ... and Consumer Protection, PartnerTech Inc. President, Gary ... Association of Georgia (TAG) for the TechAmerica DC ... leaders on legislation regarding technology along with the opportunity ... manufacturer of technology driven products, evidenced by their current ...
(Date:2/27/2015)... Javon Bea Mercy Health System President and ... open to the public, is held the second Tuesday ... Food Court, 2500 Milton Ave. Monthly meetings include a ... an educational health-related presentation. Participants receive a free t-shirt ... Health. , March 10: Using exercise to feel better ...
Breaking Medicine News(10 mins):Health News:Southern Vermont's Hermitage Club Announces Statement Regarding Vermont Attorney General Lawsuit for Permit Violations 2Health News:UAS LifeSciences to Launch UP4 Adult Cubes at Expo West 2Health News:Rise of Students Participating in Sports Creates Need for Preventative Maintenance to Gymnasium Equipment in Athletic Facilities 2Health News:Rise of Students Participating in Sports Creates Need for Preventative Maintenance to Gymnasium Equipment in Athletic Facilities 3Health News:PartnerTech Joins Technology Association of Georgia for TechAmerica DC Fly-In 2Health News:PartnerTech Joins Technology Association of Georgia for TechAmerica DC Fly-In 3
(Date:2/26/2015)... , February 26, 2015 ... (Filter, Bottle washer, Filler, Capper, Blow molder, Shrink ... Application (Still, Flavored, Sparkling) & Region - Trends ... and segments the bottled water processing market with ... in terms of value. It also identifies the ...
(Date:2/26/2015)... Feb. 26, 2015 People with psoriasis ... opportunity to participate in research that aims to ... independent U.S. psoriasis registry begins recruiting patients in ... with the National Psoriasis Foundation and Corrona, LLC, ... secukinumab, a new biologic medication by Novartis Pharmaceuticals ...
(Date:2/26/2015)... 2015  MEI Pharma, Inc. (Nasdaq: MEIP ), ... therapies for cancer, announced today that Daniel P. Gold ... the Cowen and Company 35 th Annual Health Care ... time from the Boston Marriott Copley Place. A live webcast ... A replay will be available approximately one hour after the ...
Breaking Medicine Technology:Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4First independent U.S. psoriasis registry will track drug safety and effectiveness 2First independent U.S. psoriasis registry will track drug safety and effectiveness 3MEI Pharma to Present at Cowen and Company Health Care Conference 2MEI Pharma to Present at Cowen and Company Health Care Conference 3
Cached News: